INGN Q3 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$92M+4.0% YoY

Gross Profit

$47M50.8% margin

Operating Income

-$7M-7.7% margin

Net Income

-$5M-5.7% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$64,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$307M

Total Liabilities

$110M

Stockholders' Equity

$197M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$89M	+4.0%
Gross Profit	$47M	$41M	+13.6%
Operating Income	-$7M	-$8M	+8.7%
Net Income	-$5M	-$6M	+11.2%

Geographic Segments

UNITED STATES

$54M58%

Non-US

$38M42%